Skip to main content
OpenTrials
Completed

NCT Number: NCT04860193

Audio Vestibular Functions in COVID 19 Patients in Sohag Governate

There is evidence that up to 30% of COVID-19 patients was reported with neurological manifestations such as impaired consciousness, headache, and dizziness have been reported in COVID-19 patients in addition, olfactory and taste alterations are common symptoms in patients affected by COVID-19.This study will be conducted to evaluate the effect of the novel coronavirus on audio-vestibular functions in confirmed COVID19 patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Covid19 COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

20 year–50 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Sohag faculty of medicine

Sohag, Egypt

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Well educated patients Age: range between 20 to 50 years No previous history of hearing loss or otoneurologic disease

Well confirmed COVID 19 patients:

patients who were diagnosed with coronavirus from

  • symptoms: fever, cough, generalized malaise, dyspnea.
  • Laboratory finding: abnormalities have been observed in Complete blood count (CBC), high C-reactive protein and ferritin, elevated D-dimer.
  • Imaging: Chest CT scan: bilateral ground glass opacities, crazy paving, and consolidation.
  • nasopharyngeal swab for SARS-CoV-2 polymerase chain reaction testing (RT-PCR).

Exclusion criteria

  • previous history of hearing loss or otoneurological disease

Treatment and study plan

Primary outcomes

  1. Basic audiological evaluation:

    Time frame: 3 months after infection

    Pure-tone audiometry.

  2. Basic audiological evaluation:

    Time frame: 3 months after infection

    Acoustic immittance testing

  3. Basic audiological evaluation:

    Time frame: 3 months after infection

    Speech audiometry

  4. Auditory evoked potentials:

    Time frame: 3 months after infection

    Auditory brainstem response.

  5. Auditory evoked potentials

    Time frame: 3 months after infection

    P300

  6. Effect on vestibular functions

    Time frame: 3 months after infection

    Videonystagmography

  7. Effect on vestibular functions

    Time frame: 3 months after infection

    Video Head Implus test VHIT.

  8. Effect on vestibular functions

    Time frame: 3 months after infection

    Vestibular evoked myogenic potential.

  9. Effect on vestibular functions

    Time frame: 3 months after infection

    Computerized Dynamic Posturography (CDP)

Secondary outcomes

  1. Effect on cognitive functions

    Time frame: 3 months after infection

    Cognitive function assessment:

    By Montreal test

  2. Vestibular questionnaire

    Time frame: 3 months after infection

    Dizziness Handicap Inventory (DHI).

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Audiovestibular Functions in Covid 19 Patients in Sohag Governate

Important dates

Study start
2021
Primary completion
2021
Study completion
2023
First posted
Apr 26, 2021
Registry last updated
Dec 6, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.